Submit Deal

FAGRON NV/BV

Summary

Fagron NV provides pharmaceutical compounding services to hospitals, pharmacies, clinics, and patients worldwide.

Deals Overview

Total Deals6

Valued Deals2

Total Value£40M

Avg. Deal Size£20M

Market Context

Senior Management

Rafael Padilla
CEO
Karin de Jong
CFO
Karin de Jong
CFO

Deals (6)

Service Providers

Relationships

Portfolio

Team

Sort

Belgium

IT Services: Other

DisposalPrivateMboPrivate Equity

target

Corilus

bidder

Aac Capital Partners Holding

value n/a

0 dealmakers

Mexico

Pharmaceuticals

PrivateAcquisition

target

Central De Drogas De Cv

bidder

Fagron Nv/bv

£14m

1 dealmaker

United States

Pharmaceuticals

PrivateCross BorderMajorityAcquisition

target

Letco Medical

bidder

Fagron Nv/bv

£25m

5 dealmakers

Germany

Pharmaceuticals

Cross BorderMajorityPrivateAcquisition

target

Fresenius Kabi

bidder

Fagron Nv/bv

value n/a

20 dealmakers

Germany

Biotechnology

Private EquityAcquisitionPrivateMajorityCross Border

target

Hiperscan

bidder

Fagron Nv/bv

value n/a

8 dealmakers

United Kingdom

Pharmaceuticals

AcquisitionCross BorderMajorityPrivate

target

Specialist Pharmacy

bidder

Fagron Nv/bv

value n/a

10 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.